Wound healing compositions containing alpha-1-antitrypsin
AssigneeEthicon, Inc.
InventorsMichael W. Grady, Stephen Bloor, Peter J. Doyle
Life of this patent
Estimating the term…
Abstract
The invention provides the use of alpha-1-antitrypsin for the preparation of a composition for the treatment of a chronic wound, such as a pressure sore or a venous ulcer. The composition is preferably a wound dressing composition, such as an ointment for topical application.
Claims6
A method of treating a wound comprising applying to the wound, externally, a therapeutically effective amount of alpha-1-antitrypsin, and wherein the wound is selected from the group consisting of venous ulcers, pressure sores, decubitis ulcers and diabetic ulcers.
A wound dressing composition for the treatment of wounds selected from the group consisting of venous ulcers, pressure sores, decubitis ulcers and diabetic ulcers comprising a therapeutically effective amount of alpha-1-antitrypsin, wherein the wound dressing composition is a fluid or a gel comprising from 10 to 1000 μg/ml of alpha-1-antitrypsin in combination with one or more pharmaceutical excipients for topical application to a wound.
Dependencies are inferred from the claim text.